NCD Countdown 2030 Collaborators. NCD Countdown 2030: Worldwide trends in non-communicable disease mortality and progress towards Sustainable Development Goal target 3.4. Lancet2018; 392: 1072–1088.
2.
TownsendNNicholsMScarboroughPet al.Cardiovascular disease in Europe – epidemiological update 2015. Eur Heart J2015; 36: 2696–2705.
3.
ChenBLuoLWeiXet al.Altered plasma miR-144 as a novel biomarker for coronary artery disease. Ann Clin Lab Sci2018; 48: 440–445.
4.
FichtlschererSDe RosaSFoxHet al.Circulating microRNAs in patients with coronary artery disease. Circ Res2010; 107: 677–684.
5.
SunXZhangMSanagawaAet al.Circulating microRNA-126 in patients with coronary artery disease: Correlation with LDL cholesterol. Thromb J2012; 10: 16–16.
6.
DuYYangSHLiSet al.Circulating microRNAs as novel diagnostic biomarkers for very early-onset (</=40 years) coronary artery disease. Biomed Environ Sci2016; 29: 545–554.
LeonciniPPBertainaAPapaioannouDet al.MicroRNA fingerprints in juvenile myelomonocytic leukemia (JMML) identified miR-150-5p as a tumor suppressor and potential target for treatment. Oncotarget2016; 7: 55395–55408.
9.
ZhangXHeXLiuYet al.MiR-101-3p inhibits the growth and metastasis of non-small cell lung cancer through blocking PI3K/AKT signal pathway by targeting MALAT-1. Biomed Pharmacother2017; 93: 1065–1073.
10.
WuXZhouJWuZet al.miR-101-3p suppresses HOX Transcript Antisense RNA (HOTAIR)-induced proliferation and invasion through directly targeting SRF in gastric carcinoma cells. Oncol Res2017; 25: 1383–1390.
11.
WangMHuMLiZet al.miR-141-3p functions as a tumor suppressor modulating activating transcription factor 5 in glioma. Biochem Biophys Res Commun2017; 490: 1260–1267.
12.
WuJCuiHZhuZet al.MicroRNA-200b-3p suppresses epithelial-mesenchymal transition and inhibits tumor growth of glioma through down-regulation of ERK5. Biochem Biophys Res Commun2016; 478: 1158–1164.
13.
IshibashiOAkagiIOgawaYet al.MiR-141-3p is upregulated in esophageal squamous cell carcinoma and targets pleckstrin homology domain leucine-rich repeat protein phosphatase-2, a negative regulator of the PI3K/AKT pathway. Biochem Biophys Res Commun2018; 501: 507–513.
14.
HortmannMWalterJEBenningLet al.Droplet digital PCR of serum miR-499, miR-21 and miR-208a for the detection of functionally relevant coronary artery disease. Int J Cardiol2018. pii: S0167-5273(18): 32300–32303. DOI: 10.1016/j.ijcard.2018.08.031.
15.
PanRYLiuPZhouHTet al.Circular RNAs promote TRPM3 expression by inhibiting hsa-miR-130a-3p in coronary artery disease patients. Oncotarget2017; 8: 60280–60290.
16.
BildiriciAEArslanSOzbilum SahinNet al.MicroRNA-221/222 expression in atherosclerotic coronary artery plaque versus internal mammarian artery and in peripheral blood samples. Biomarkers2018; 23: 670–675.
17.
ZhouKYuePMaFet al.Interpreting the various associations of MiRNA polymorphisms with susceptibilities of cardiovascular diseases: Current evidence based on a systematic review and meta-analysis. Medicine (Baltimore)2018; 97: e10712–e10712.
18.
LeeGTwerenboldRTanglayYet al.Clinical benefit of high-sensitivity cardiac troponin I in the detection of exercise-induced myocardial ischemia. Am Heart J2016; 173: 8–17.
